Germany's Immatics ties up with GSK to develop immunotherapies

German biopharmaceutical firm Immatics said on Thursday it plans to collaborate with British drugmaker GlaxoSmithKline (GSK) to develop immunotherapies targeting multiple cancer indications, with a focus on solid tumours.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news